Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Fedorak

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammationI Soo, K L Madsen, Q Tejpar, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend studyK M Reich, H-J Chang, A Rezaie, et al.
The American Journal of Physiology|February 12, 1998
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestineK L Madsen, M M Tavernini, C Yachimec, et al.
Gut|February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialW J Sandborn, S B Hanauer, P Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohortA W G Waugh, S Garg, K Matic, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammationI Soo, K L Madsen, Q Tejpar, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend studyK M Reich, H-J Chang, A Rezaie, et al.
The American Journal of Physiology|February 12, 1998
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestineK L Madsen, M M Tavernini, C Yachimec, et al.
Gut|February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialW J Sandborn, S B Hanauer, P Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohortA W G Waugh, S Garg, K Matic, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.
Pageof 9